Advice
Development of this evidence summary
The evidence summary: process guide (2017) sets out the process NICE uses to select topics for evidence summaries and details how the summaries are developed, quality assured and approved for publication.
Expert advisers
Dr Enrico Bugiardini Clinical Research Associate MRC centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology.
Professor Patrick Chinnery Professor of Neurology and Head of the Department of Clinical Neurosciences, University of Cambridge.
Professor Michael G Hanna Consultant Neurologist and Director of the UCL Institute of Neurology MRC centre for Neuromuscular Diseases, Department of Molecular Neuroscience, UCL Institute of Neurology.
Declarations of interest
Dr Enrico Bugiardini: no relevant interests declared.
Professor Chinnery: principal investigator on an industry-led study in the treatment of mitochondrial disease. This was not a paid role.
Professor Michael G Hanna: no relevant interests declared.
|
About this evidence summary Evidence summaries provide a summary of the best available published evidence for selected new medicines, unlicensed medicines or off-label use of licensed medicines. The summaries assess the strengths and weaknesses of the best available evidence to inform health professionals and commissioners' decision-making. This summary is not NICE guidance. |
ISBN: 978-1-4731-2397-7